Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:ABBV
Tag: NYSE:ABBV
Insider Trading Activity AbbVie Inc. (NYSE:ABBV) – Insider Sold 18,000 shares...
ME Staff
-
August 2, 2017
0
Insider Trading Activity AbbVie Inc. (NYSE:ABBV) – Director Bought 4,000 shares...
ME Staff
-
August 2, 2017
0
Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Maviret Authorized For Sale In EU
Andy Parker
-
August 2, 2017
0
AbbVie Inc. (NYSE:ABBV) reported earnings of $1.42 per share beating Walls...
ME Staff
-
July 28, 2017
0
ABBVIE INC. (NYSE:ABBV) Files An 8-K Results of Operations and Financial...
ME Staff 8-k
-
July 28, 2017
0
AbbVie Inc. (NYSE:ABBV) Shrugs Of Humira Dependence Concerns With Robust Pipeline
-
July 26, 2017
0
AbbVie Inc. (NYSE:ABBV): CHMP Okays Humira As Treatment For Uveitis
Andy Parker
-
July 24, 2017
0
Analyst Activity – Credit Suisse Group Reiterates Neutral on AbbVie (NYSE:ABBV)
ME Staff
-
July 20, 2017
0
Analyst Activity – Credit Suisse Group Reiterates Neutral on AbbVie (NYSE:ABBV)
ME Staff
-
July 20, 2017
0
Gilead Sciences, Inc. (NASDAQ:GILD) HCV Portfolio Strengthened With Vosevi Approval
Andy Parker
-
July 20, 2017
0
1
...
7
8
9
...
13
Page 8 of 13
